Trisubstituted heterocycles as replication inhibitors of hepatitis C virus HCV

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

Bibliographische Detailangaben

Hauptverfasser:	Califano Jean C, Motter Christopher E, Wagaw Seble H, Kati Warren M, Flentge Charles A, Pratt John K, Liu Dachun, Betebenner David A, Wagner Rolf, Keddy Ryan G, Donner Pamela L, Caspi Daniel.D, Maring Clarence J, Woller Kevin R, Hutchins Charles W, Patel Sachin V, Sarris Kathy, Degoey David A, Bellizzi Mary E, Nelson Lissa T, Tufano Michael D, Jinkerson Tammie K, Hutchinson Douglas K, Gao Yi, Krueger Allan C, Matulenko Mark A, Li Wenke, Rockway Todd W, Randolph John T
Format:	Patent
Sprache:	eng ; slv
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!